- $1.92bn
- $3.81bn
- $2.83bn
- 70
- 63
- 33
- 54
2019 September 30th | 2020 September 30th | R2021 September 30th | R2022 September 30th | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,807 | 2,517 | 2,241 | 2,315 | 2,826 |
Cost of Revenue | |||||
Gross Profit | 624 | 816 | 732 | 766 | 950 |
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,597 | 2,462 | 1,961 | 2,051 | 2,531 |
Operating Profit | 211 | 54.9 | 281 | 264 | 295 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 177 | -18.5 | 207 | 200 | 217 |
Provision for Income Taxes | |||||
Net Income After Taxes | 126 | -53.4 | 128 | 116 | 114 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 121 | -60.1 | 250 | 209 | 570 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 121 | -60.1 | 250 | 209 | 570 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.22 | 1.27 | 1.17 | 1.83 | 2 |
Dividends per Share |